Drug-induced keratoderma

From WikiMD's WELLNESSPEDIA


Drug-induced keratoderma
Synonyms
Pronounce N/A
Specialty Dermatology
Symptoms Thickening of the skin on the palms and soles
Complications
Onset
Duration
Types N/A
Causes Drug reaction
Risks
Diagnosis Clinical diagnosis
Differential diagnosis Palmoplantar keratoderma, Psoriasis, Eczema
Prevention Avoidance of causative drugs
Treatment Discontinuation of the offending drug, topical treatments
Medication Keratolytics, Emollients
Prognosis Generally good with drug discontinuation
Frequency Rare
Deaths N/A


Drug-induced keratoderma is a condition characterized by the thickening of the skin on the palms of the hands and the soles of the feet. This condition is caused by the use of certain medications.

Causes[edit]

Drug-induced keratoderma is caused by the use of certain medications. These medications include retinoids, cytotoxic drugs, and antiretroviral drugs. The exact mechanism by which these drugs cause keratoderma is not fully understood.

Symptoms[edit]

The main symptom of drug-induced keratoderma is the thickening of the skin on the palms of the hands and the soles of the feet. This thickening can be accompanied by other symptoms such as redness, itching, and pain.

Diagnosis[edit]

The diagnosis of drug-induced keratoderma is made based on the patient's medical history, physical examination, and the results of skin biopsy. The skin biopsy can show characteristic changes in the skin that are indicative of keratoderma.

Treatment[edit]

The treatment of drug-induced keratoderma involves discontinuing the offending medication and treating the symptoms. Topical treatments such as emollients and keratolytics can be used to soften the skin and reduce the thickness of the skin. In severe cases, systemic treatments such as retinoids may be used.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.